Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery Hospital
Explore linked clinical trials.22 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors | Biliary Tract Tumors | Active, not recruiting | Phase 2 | 2026-08-24 | NCT06892925 | |
| Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-07-23 | NCT06238713 | |
| Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, focal nodular hyperplasia, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, liver disorder, neoplasm | Not yet recruiting | Not stated | 2026-07-16 | NCT07707661 | |
| Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm | Not yet recruiting | Phase 2 | 2026-06-10 | NCT07638501 | |
| Effects of Short-term Perioperative Daidzein Intervention on Liver Histopathology in Patients With MASLD | metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Phase 2 | 2026-06-03 | NCT07623044 | |
| HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC | intrahepatic cholangiocarcinoma | Recruiting | Phase 2 | 2026-01-23 | NCT07364305 | |
| Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer | Hepatocellular Carcinoma Resectable | Not yet recruiting | Phase 2 | 2026-01-23 | NCT07363356 | |
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers | Advanced Biliary Tract Cancer(BTC) | Not yet recruiting | Phase 2 | 2026-01-20 | NCT07351591 | |
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma | Not yet recruiting | Phase 2 | 2026-01-20 | NCT07351513 | |
| A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Not applicable | 2026-01-13 | NCT07337031 | |
| The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 / Phase 3 | 2025-12-16 | NCT07285850 | |
| A Study of TIL in Advanced Solid Tumors (DFGD) | Advanced Solid Tumor; Effects of Immunotherapy; Treatment Side Effects; Tumor Infiltrating Lymphocytes | Recruiting | Early phase 1 | 2025-12-16 | NCT06488950 | |
| Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 3 | 2025-09-22 | NCT07186621 | |
| Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2025-09-12 | NCT07170345 | |
| Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm | Active, not recruiting | Phase 2 / Phase 3 | 2025-09-04 | NCT04669496 | |
| A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | Phase 1 / Phase 2 | 2025-09-03 | NCT06902389 | |
| Bile Omics for Diagnosing Indeterminate Biliary Strictures | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, endocrine system disorder, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2025-06-11 | NCT07007832 | |
| Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study | Dynamic Prediction Model; Immunotherapy; Unresectable Biliary Tract Cancer | Recruiting | Not stated | 2025-02-27 | NCT06849193 | |
| Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, combined hepatocellular carcinoma and cholangiocarcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2025-02-27 | NCT06849180 | |
| Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis | Post ERCP Pancreatitis | Recruiting | Phase 3 | 2025-02-12 | NCT03713879 | |
| Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm | Not yet recruiting | Phase 4 | 2025-02-10 | NCT06818773 | |
| Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2024-07-31 | NCT06530823 |